Safety aspects of gonadotrophin-releasing hormone antagonists in ovarian stimulation procedures: ovarian hyperstimulation syndrome and health of children born

Reproductive BioMedicine Online ◽

10.1016/s1472-6483(11)60219-8 ◽

2002 ◽

Vol 5 ◽

pp. 61-67 ◽

Author(s):

M Ludwig ◽

A Katalinic ◽

RE Felberbaum ◽

K Diedrich

Keyword(s):

Ovarian Stimulation ◽

Ovarian Hyperstimulation Syndrome ◽

Ovarian Hyperstimulation ◽

Releasing Hormone ◽

Safety Aspects ◽

Gonadotrophin Releasing Hormone ◽

Hormone Antagonists

Download Full-text

High dose gonadotrophin-releasing hormone antagonist (ganirelix) may prevent ovarian hyperstimulation syndrome caused by ovarian stimulation for in-vitro fertilization

Human Reproduction ◽

10.1093/humrep/13.3.573 ◽

1998 ◽

Vol 13 (3) ◽

pp. 573-575 ◽

Author(s):

D. de Jong ◽

N. S. Macklon ◽

B. M. Mannaerts ◽

H. J. Coelingh Bennink ◽

B. C. Fauser

Keyword(s):

In Vitro Fertilization ◽

Ovarian Stimulation ◽

Ovarian Hyperstimulation Syndrome ◽

High Dose ◽

Ovarian Hyperstimulation ◽

Vitro Fertilization ◽

Releasing Hormone ◽

Gonadotrophin Releasing Hormone

Download Full-text

Is continuation of a gonadotrophin-releasing hormone agonist (GnRHa) necessary for women at risk of developing the ovarian hyperstimulation syndrome?

Human Reproduction ◽

10.1093/oxfordjournals.humrep.a137798 ◽

1992 ◽

Vol 7 (8) ◽

pp. 1090-1093 ◽

Author(s):

I. Wada ◽

P.L. Matson ◽

G. Horne ◽

P. Buck ◽

B.A. Lieberman

Keyword(s):

At Risk ◽

Ovarian Hyperstimulation Syndrome ◽

Ovarian Hyperstimulation ◽

Releasing Hormone ◽

Gonadotrophin Releasing Hormone

Download Full-text

Authors’ reply re: Serum vascular endothelial growth factor levels following luteal gonadotrophin-releasing hormone antagonist administration in women with severe early ovarian hyperstimulation syndrome

BJOG An International Journal of Obstetrics & Gynaecology ◽

10.1111/1471-0528.13068 ◽

2015 ◽

Vol 122 (4) ◽

pp. 585-586

Author(s):

TG Lainas ◽

EM Kolibianakis

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Ovarian Hyperstimulation Syndrome ◽

Ovarian Hyperstimulation ◽

Vascular Endothelial ◽

Releasing Hormone ◽

Gonadotrophin Releasing Hormone ◽

Endothelial Growth Factor

Download Full-text

Triggering the final stage of ovulation using gonadotrophin-releasing hormone analogues: effective dose, prevention of ovarian hyperstimulation syndrome and the luteal phase

Human Reproduction ◽

10.1093/oxfordjournals.humrep.a019341 ◽

1996 ◽

Vol 11 (6) ◽

pp. 1146-1148 ◽

Author(s):

A. Ben-Arie ◽

A. Weissman ◽

Z. Shoham

Keyword(s):

Effective Dose ◽

Final Stage ◽

Luteal Phase ◽

Ovarian Hyperstimulation Syndrome ◽

Ovarian Hyperstimulation ◽

Releasing Hormone ◽

Gonadotrophin Releasing Hormone

Download Full-text

Gonadotrophin-releasing hormone agonist and ovarian hyperstimulation syndrome in assisted reproduction

Human Reproduction ◽

10.1093/oxfordjournals.humrep.a137973 ◽

1993 ◽

Vol 8 (12) ◽

pp. 2009-2014 ◽

Author(s):

Nathan Mordel ◽

Joseph G. Schenker

Keyword(s):

Assisted Reproduction ◽

Ovarian Hyperstimulation Syndrome ◽

Ovarian Hyperstimulation ◽

Releasing Hormone ◽

Gonadotrophin Releasing Hormone

Download Full-text

Re: Serum vascular endothelial growth factor levels following luteal gonadotrophin-releasing hormone antagonist administration in women with severe early ovarian hyperstimulation syndrome

BJOG An International Journal of Obstetrics & Gynaecology ◽

10.1111/1471-0528.13067 ◽

2015 ◽

Vol 122 (4) ◽

pp. 585-585

Author(s):

HS Ko ◽

N Kim ◽

Y-G Park

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Ovarian Hyperstimulation Syndrome ◽

Ovarian Hyperstimulation ◽

Vascular Endothelial ◽

Releasing Hormone ◽

Gonadotrophin Releasing Hormone ◽

Endothelial Growth Factor

Download Full-text

Does triggering ovulation with gonadotrophin-releasing hormone analogue prevent severe ovarian hyperstimulation syndrome?

Human Reproduction ◽

10.1093/oxfordjournals.humrep.a019340 ◽

1996 ◽

Vol 11 (6) ◽

pp. 1144-1146 ◽

Author(s):

R. F. Casper

Keyword(s):

Ovarian Hyperstimulation Syndrome ◽

Ovarian Hyperstimulation ◽

Hormone Analogue ◽

Releasing Hormone ◽

Gonadotrophin Releasing Hormone ◽

Severe Ovarian Hyperstimulation Syndrome

Download Full-text

Ovarian Hyperstimulation Syndrome Prevention Strategies: Use of Gonadotropin-Releasing Hormone Antagonists

Seminars in Reproductive Medicine ◽

10.1055/s-0030-1265676 ◽

2010 ◽

Vol 28 (06) ◽

pp. 493-499 ◽

Author(s):

Georg Griesinger

Keyword(s):

Ovarian Hyperstimulation Syndrome ◽

Gonadotropin Releasing Hormone ◽

Ovarian Hyperstimulation ◽

Prevention Strategies ◽

Releasing Hormone ◽

Gonadotropin Releasing Hormone Antagonists ◽

Hormone Antagonists

Download Full-text

Endocrinology: Comparison of gonadotrophin-releasing hormone analogues and human chorionic gonadotrophin for the induction of ovulation and prevention of ovarian hyperstimulation syndrome: a case-control study

Human Reproduction ◽

10.1093/oxfordjournals.humrep.a019407 ◽

1996 ◽

Vol 11 (7) ◽

pp. 1399-1402 ◽

Author(s):

N. Lewit ◽

S. Kol ◽

D. Manor ◽

J. Itskovitz-Eldor

Keyword(s):

Ovarian Hyperstimulation Syndrome ◽

Case Control Study ◽

Case Control ◽

Chorionic Gonadotrophin ◽

Human Chorionic Gonadotrophin ◽

Ovarian Hyperstimulation ◽

Releasing Hormone ◽

Induction Of Ovulation ◽

Gonadotrophin Releasing Hormone ◽

Download Full-text

Endocrinology: Triggering of ovulation using a gonadotrophin-releasing hormone agonist does not prevent ovarian hyperstimulation syndrome

Human Reproduction ◽

10.1093/oxfordjournals.humrep.a137903 ◽

1993 ◽

Vol 8 (10) ◽

pp. 1628-1631 ◽

Author(s):

S. van der Meer ◽

J. Gerris ◽

M. Joostens ◽

B. Tas

Keyword(s):

Ovarian Hyperstimulation Syndrome ◽

Ovarian Hyperstimulation ◽

Releasing Hormone ◽

Gonadotrophin Releasing Hormone

Download Full-text